Product Information
Registration Status: ActiveROSIDEN GEL is approved to be sold in Singapore with effective from 1990-03-10. It is marketed by ZYFAS MEDICAL CO, with the registration number of SIN05100P.
This product contains Piroxicam 5mg/g in the form of GEL. It is approved for TOPICAL use.
This product is manufactured by SHIN POONG PHARMACEUTICAL CO LTD in KOREA, and in REPUBLIC OF.
It is a Pharmacy Only Medicine that can be obtained from a pharmacist at a retail pharmacy.
Description
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. [PubChem]
Indication
For treatment of osteoarthritis and rheumatoid arthritis.
Mechanism of Action
The antiinflammatory effect of Piroxicam may result from the reversible inhibition of cyclooxygenase, causing the peripheral inhibition of prostaglandin synthesis. The prostaglandins are produced by an enzyme called Cox-1. Piroxicam blocks the Cox-1 enzyme, resulting into the disruption of production of prostaglandins. Piroxicam also inhibits the migration of leukocytes into sites of inflammation and prevents the formation of thromboxane A2, an aggregating agent, by the platelets.
Pharmacokinetics
- Absorption
- Well absorbed following oral administration.
- Distribution
- * 0.14 L/kg
- Metabolism
- Renal
- Elimination
Toxicity
Symptoms of overdose include drowsiness, nausea, stomach pain, and/or vomiting.
Active Ingredient/Synonyms
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid | Piroxicam | Piroxicam betadex | Piroxicamum | Pyroxycam | Piroxicam |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.